Researchers at NYU said that an experimental drug that blocks a key protein can trigger a form of self-destruction in lung ...

The country's first clinical practice guidelines (CPG) for managing early-stage resectable non-small cell lung cancer (NSCLC) ...

Early-stage lung adenocarcinoma alters DNA methylation, mRNA transcription, and protein expression in adjacent tissues, exhibiting either steep changes at the tumor boundaries or shallow changes ...

NYU Langone Health researchers found that a type of cell death caused by a buildup of highly reactive molecules suppresses lung tumor growth.

A "disastrous" laboratory error that led to an incorrect diagnosis of lung cancer was linked to the man's subsequent death ...

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...

Blocking the action in cancer cells of a key protein reduced by up to 80% tumor growth in mice with a common type of lung cancer.

REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS), today announced that Arvind Sood has joined the Company as Chief Strategy and Corporate Affairs Officer ...

CHS-114, a highly selective Treg depleter, clinical program expanded to include colorectal cancer –– Q3 2025 ending cash, cash equivalents and ...

Scientific evidence confirms air pollution causes lung cancer even in non-smokers. Experts warn urgent lifestyle changes and ...